[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[2] Li T, Mello-Thoms C, Brennan PC. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence [J]. Breast Cancer Res Treat, 2016, 159(3): 395-406.
[3] Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[4] Armer JM, Stewart BR, Shook RP. 30-month post-breast cancer treatment lymphoedema [J]. J Lymphoedema, 2009, 4(1): 14-18.
[5] Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema [J]. CA Cancer J Clin, 2015, 65(1): 55-81.
[6] Czerniec SA, Ward LC, Refshauge KM, et al. Assessment of breast cancer-related arm lymphedema–comparison of physical measurement methods and self-report [J]. Cancer Invest, 2010, 28(1): 54-62.
[7] International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology [J]. Lymphology, 2013, 46(1): 1-11.
[8] Dylke ES, Yee J, Ward LC, et al. Normative volume difference between the dominant and nondominant upper limbs in healthy older women [J]. Lymphat Res Biol, 2012, 10(4): 182-188.
[9] Kilbreath SL, Dylke EC, Ward LC. Bioimpedance spectroscopy does have a valid and evidence-based role in detection and monitoring of lymphoedema [J]. J Surg Oncol, 2017, 115(2): 221-222.
[10] Shah C, Arthur DW, Wazer D, et al. The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review [J]. Cancer Med, 2016, 5(6): 1154-1162.
[11] Vignes S, Blanchard M, Arrault M, et al. Intensive complete decongestive physiotherapy for cancer-related upper-limb lymphedema: 11 days achieved greater volume reduction than 4 [J]. Gynecol Oncol, 2013, 131(1): 127-130.
[12] Leard T, Barrett C. Successful management of severe unilateral lower extremity lymphedema in an outpatient setting [J]. Phys Ther, 2015, 95(9): 1295-1306.
[13] Leung N, Furniss D, Giele H. Modern surgical management of breast cancer therapy related upper limb and breast lymphoedema [J]. Maturitas, 2015, 80(4): 384-390.
[14] American Physical Therapy Association. Guide to Physical Therapist Practice. Second Edition. American Physical Therapy Association [J]. Phys Ther, 2001, 81(1): 9-746.
[15] Gardner GC, Nickerson JP, Watts R, et al. Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0 T MRI to external measures [J]. Lymphat Res Biol, 2014, 12(2): 95-102.
[16] Mihara M, Hayashi Y, Hara H, et al. High-accuracy diagnosis and regional classification of lymphedema using indocyanine green fluorescent lymphography after gynecologic cancer treatment [J]. Ann Plast Surg, 2014, 72(2): 204-208.
[17] Foldi M. Földi's Textbook of Lymphology: For Physicians and Lymphedema Therapists [M]. München: Elsevier GmbH, Urban & Fischer Verlag, 2006.
[18] 段艳芹,李惠萍. 乳腺癌患者术后上肢淋巴水肿的评估与预防进展[J]. 中华护理杂志, 2010, 45(11): 1048-1050.
[19] Brorson AKGS. Lymphedema–Presentation, Diagnosis, and Treatment [M]. London: Springer International Publishing, 2015.
[20] Hamner JB, Fleming MD. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer [J]. Ann Surg Oncol, 2007, 14(6): 1904-1908.
[21] Byung-Boong Lee JBSG. Lymphedema–A Concise Compendium of Theory and Practice [M]. London: Springer-Verlag, 2011: 599.
[22] Norman SA, Miller LT, Erikson HB, et al. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer [J]. Phys Ther, 2001, 81(6): 1192-1205.
[23] 刘瑾,路潜,欧阳倩,等. Norman电话问卷用于乳腺癌术后淋巴水肿判断效果的检测[J]. 护理学杂志, 2015, 30(24): 36-38.
[24] Armer JM, Radina ME, Porock D, et al. Predicting breast cancer-related lymphedema using self-reported symptoms [J]. Nurs Res, 2003, 52(6): 370-379.
[25] Armer J, Fu MR, Wainstock JM, et al. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy [J]. Lymphology, 2004, 37(2): 73-91.
[26] Ridner SH, Dietrich MS. Development and validation of the Lymphedema Symptom and Intensity Survey-Arm [J]. Support Care Cancer, 2015, 23(10): 3103-3112.
[27] Wiig H, Swartz MA. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer [J]. Physiol Rev, 2012, 92(3): 1005-1060.
[28] Stemmer R. Stemmer's sign–possibilities and limits of clinical diagnosis of lymphedema [J]. Wien Med Wochenschr, 1999, 149(2-4): 85-86.
[29] Sanderson J, Tuttle N, Box R, et al. The pitting test; an investigation of an unstandardized assessment of lymphedema [J]. Lymphology, 2015, 48(4): 175-183.
[30] Stanton AW, Northfield JW, Holroyd B, et al. Validation of an optoelectronic limb volumeter (Perometer) [J]. Lymphology, 1997, 30(2): 77-97.
[31] Ward LC. Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring [J]. Lymphat Res Biol, 2006, 4(1): 51-56.
[32] Tan IC, Maus EA, Rasmussen JC, et al. Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging [J]. Arch Phys Med Rehabil, 2011, 92(5): 756-764.
[33] Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population [J]. Lymphat Res Biol, 2005, 3(4): 208-217.
[34] Sander AP, Hajer NM, Hemenway K, et al. Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume [J]. Phys Ther, 2002, 82(12): 1201-1212.
[35] Bernas MJ, Askew RL, Armer JM, et al. Lymphedema: how do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment? [J]. Current Breast Cancer Reports, 2010, 2(1): 53-58.
[36] Hayes S, Janda M, Cornish B, et al. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors [J]. Lymphology, 2008, 41(1): 18-28.
[37] Hayes SC, Speck RM, Reimet E, et al. Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial [J]. Breast Cancer Res Treat, 2011, 130(1): 227-234.
[38] Wilhelm MC, Saul PB, Morgan JA. Post-mastectomy lymphedema [J]. Va Med Mon (1918), 1974, 101(6): 465-469.
[39] Haines TP, Sinnamon P. Early arm swelling after breast surgery: changes on both sides [J]. Breast Cancer Res Treat, 2007, 101(1): 105-112.
[40] Sagen A, Karesen R, Skaane P, et al. Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery [J]. Arch Phys Med Rehabil, 2009, 90(5): 803-809.
[41] Swedborg I. Voluminometric estimation of the degree of lymphedema and its therapy by pneumatic compression [J]. Scand J Rehabil Med, 1977, 9(3): 131-135.
[42] Czerniec SA, Ward LC, Lee MJ, et al. Segmental measurement of breast cancer-related arm lymphoedema using perometry and bioimpedance spectroscopy [J]. Support Care Cancer, 2011, 19(5): 703-710.
[43] Stout NL, Pfalzer LA, Levy E, et al. Segmental limb volume change as a predictor of the onset of lymphedema in women with early breast cancer [J]. PM R, 2011, 3(12): 1098-1105.
[44] Tierney S, Aslam M, Rennie K, et al. Infrared optoelectronic volumetry, the ideal way to measure limb volume [J]. Eur J Vasc Endovasc Surg, 1996, 12(4): 412-417.
[45] Cornish B. Bioimpedance analysis: scientific background [J]. Lymphat Res Biol, 2006, 4(1): 47-50.
[46] Cornish BH, Ward LC. Data analysis in multiple-frequency bioelectrical impedance analysis [J]. Physiol Meas, 1998, 19(2): 275-283.
[47] Ward LC, Dylke E, Czerniec S, et al. Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy [J]. Lymphat Res Biol, 2011, 9(1): 47-51.
[48] Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance [J]. Lymphology, 2001, 34(1): 2-11.
[49] Ridner SH, Dietrich MS, Deng J, et al. Bioelectrical impedance for detecting upper limb lymphedema in nonlaboratory settings [J]. Lymphat Res Biol, 2009, 7(1): 11-15.
[50] Szuba A, Shin WS, Strauss HW, et al. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema [J]. J Nucl Med, 2003, 44(1): 43-57.
[51] Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients [J]. Radiology, 1988, 167(3): 729-735.
[52] Liu N, Wang C, Sun M. Noncontrast three-dimensional magnetic resonance imaging vs lymphoscintigraphy in the evaluation of lymph circulation disorders: a comparative study [J]. J Vasc Surg, 2005, 41(1): 69-75.
[53] Liu NF, Lu Q, Jiang ZH, et al. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography [J]. J Vasc Surg, 2009, 49(4): 980-987.
[54] Unno N, Inuzuka K, Suzuki M, et al. Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema [J]. J Vasc Surg, 2007, 45(5): 1016-1021.
[55] 王雪鹃. 应用近红外荧光淋巴显像诊断正常肢体及淋巴水肿[J]. 中国医学影像学杂志, 2011, 19(6): 476-480.
[56] Rasmussen JC, Tan IC, Marshall MV, et al. Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence [J]. Transl Oncol, 2010, 3(6): 362-372.
